Document is current
Any future updates will be listed below
-
Authors
Johnsen, Bjarne
Kaschubowski, Klaus Eric
Nader, Sorush
Schneider, Enja
Nicola, Jan-Andrei
Fliegert, Ralf
Wolf, Insa M. A.
Guse, Andreas H.
Nikolaev, Viacheslav O.
Koch-Nolte, Friedrich
Haag, Friedrich https://orcid.org/0000-0001-6555-3106
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (HA2369/5, SFB1328 Project A12)
- License Information
-
More Information
Article History
Received: 19 July 2018
Accepted: 13 March 2019
First Online: 23 April 2019
Compliance with ethical standards
:
: BJ, KEK, SN, ES, JAN, RF, IMAW, AHG, and VON declare that they have no conflict of interest. FKN and FH received royalties from the sales of antibodies developed in the laboratory via MediGate GmbH, a 100% subsidiary of the University Medical Center, Hamburg. FKN is also an inventor on patent applications on P2X7-specific nanobodies.
: This article does not contain any studies with human participants or animals performed by any of the authors.
